Targeted genomic disruption of h-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism

[EN]The aim of the present experiments was to evaluate the differences in arterial pressure between H-Ras lacking mice and control mice and to analyze the mechanisms involved in the genesis of the differences. H-Ras lacking mice and mouse embryonic fibroblasts from these animals were used. Blood pre...

ver descrição completa

Detalhes bibliográficos
Autores: Chamorro-Jorganes, Aranzazu, Grande, Maria Teresa, Herranz, Beatriz, Jerkic, Mirjana, Griera, Mercedes, González Núñez, María, Santos de Dios, Eugenio Miguel, Rodríguez-Puyol, Diego, López-Novoa, José M., Rodriguez-Puyol, Manuel
Formato: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2010
País:España
Recursos:Universidad de Salamanca (USAL)
Repositorio:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/155341
Acesso em linha:http://hdl.handle.net/10366/155341
Access Level:acceso embargado
Palavra-chave:Arterial pressure
cGMP-dependent protein kinase
Cyclic GMP
H-Ras protein
Nitric oxide
Soluble guanylyl cyclase
Aorta
Fibroblasts
Cells
Nitric Oxide
Statistics
Blood Pressure
Hypotension
Cyclic GMP-Dependent Protein Kinases
Guanylate Cyclase
Phosphorylation
Nitric Oxide Synthase Type III
Immunohistochemistry
Animals
Signal Transduction
Up-Regulation
ras Proteins
Mice
inmunohistoquímica
fibroblastos
hipotensión
transducción de señales
ratones
óxido nítrico
guanilato ciclasa
regulación positiva
proteínas ras
proteínas cinasas dependientes de GMP cíclico
presión sanguínea
aorta
células
animales
estadísticas
GMP cíclico
óxido nítrico sintasa de tipo III
fosforilación
Descrição
Resumo:[EN]The aim of the present experiments was to evaluate the differences in arterial pressure between H-Ras lacking mice and control mice and to analyze the mechanisms involved in the genesis of the differences. H-Ras lacking mice and mouse embryonic fibroblasts from these animals were used. Blood pressure was measured using 3 different methods: direct intraarterial measurement in anesthetized animals, tail-cuff sphygmomanometer, and radiotelemetry. H-Ras lacking mice showed lower blood pressure than control animals. Moreover, the aorta protein content of endothelial nitric oxide synthase, soluble guanylyl cyclase, and cyclic guanosine monophosphate-dependent protein kinase was higher in H-Ras knockout mice than in control animals. The activity of these enzymes was increased, because urinary nitrite excretion, sodium nitroprusside-stimulated vascular cyclic guanosine monophosphate synthesis, and phosphorylated vasoactive-stimulated phosphoprotein in aortic tissue increased in these animals. Furthermore, mouse embryonic fibroblasts from H-Ras lacking mice showed higher cyclic guanosine monophosphate-dependent protein kinase promoter activity than control cells. These results strongly support the upregulation of the nitric oxide-cyclic guanosine monophosphate pathway in H-Ras-deficient mice. Moreover, they suggest that H-Ras pathway could be considered as a therapeutic target for hypertension treatment.